XML 39 R37.htm IDEA: XBRL DOCUMENT v2.4.0.8
COLLABORATIVE ARRANGEMENTS (Details 4) (Commercialization Agreement, Clinigen, VIBATIV, USD $)
3 Months Ended 9 Months Ended
Mar. 31, 2013
Sep. 30, 2013
Item
Information related to collaborative arrangements    
Upfront payment $ 5,000,000  
Period of advance notice to terminate the agreement   12 months
Number of units of accounting based on the relative selling price method   2
Upfront payment received allocated to license 4,900,000  
Upfront payment received allocated to committee participation $ 100,000  
Minimum
   
Information related to collaborative arrangements    
Royalty rate, as a percentage of net sales   20.00%
Agreement term   15 years
Maximum
   
Information related to collaborative arrangements    
Royalty rate, as a percentage of net sales   30.00%